Anchoring Your Portfolio: Is ATAI Stock a Safe Harbor?

Currently, the stock price of ATAI Life Sciences N.V (ATAI) is $3.23. In the most recent trading session, the stock underwent a significant upswing, peaking at $12.0 after opening at $3.23. The stock touched a low of $6.0 before closing at $2.79.

The stock market performance of ATAI Life Sciences N.V has been very steady. Over the last year, the company’s stock hit its highest at $2.98 on 07/18/25, while the lowest price during the same time frame was $1.03, recorded on 10/11/24.

52-week price history of ATAI Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. ATAI Life Sciences N.V’s current trading price is 8.21% away from its 52-week high, while its distance from the 52-week low is 213.59%. The stock’s price range during this period has fluctuated between $1.03 and $2.98. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 14.87 million for the day, which was evidently higher than the average daily volume of 3.51 million over the last three months.

Financial Performance and Market Capitalization

ATAI Life Sciences N.V (ATAI) has experienced a quarterly rise of 127.46% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 648.43M and boasts a workforce of 54 employees.

Analysts’ Ratings For ATAI Life Sciences N.V

As of right now, 6 analysts are rating ATAI Life Sciences N.V as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.85, with a change in price of +1.41. Similarly, ATAI Life Sciences N.V recorded 2,979,897 in trading volume during the last 100 days, posting a change of +77.47%.

ATAI Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ATAI stands at 0.19. Similarly, the long-term debt-to-equity ratio is also 0.09.

ATAI Stock Stochastic Average

ATAI Life Sciences N.V’s raw stochastic average for the past 50 days is currently at 94.17%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 91.11%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 80.79% and 74.42%, respectively.

ATAI Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price increase of 96.95%. However, over the past six months, we’ve seen a weaker performance of 124.31%. The price of ATAI fallen by 45.50% over the last 30 days. And in the last five days, it has surged by 23.28%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.